1. Poster Abstract from ID Week 2016 – Reducing SSIR Rates with Nozin Nasal Sanitizer

    January 27, 2017

    Baylor Orthopedic and Spine Hospital at Arlington, Texas presented a poster at ID Week 2016: Pre- and Post-Operative Participation of Orthopedic Patients and Surgical Staff in a Novel Intervention to Reduce Staphylococcus aureus Infection.The premise of the poster abstract presentation was “overall reduction of potentially infectious bacteria in the immediate patient environment is critical to effective infection control […]


  2. Antimicrobial Stewardship Boosts Outcomes for MRSA

    April 14, 2016

    Daily monitoring of patients receiving antimicrobial injections targeting methicillin-resistant Staphylococcus aureus (MRSA) is associated with improved clinical outcomes, according to a study published online in the Journal of Clinical Pharmacy and Therapeutics. The study included daily reviews of prescriptions and the review occurred within 24 hours after initiation of therapy. The researchers found that implementation of daily review correlated […]


  3. New Guidelines for Hospital Visitors of Patients with Infectious Diseases Nozin Pro Blog

    New Guidelines for Hospital Visitors of Patients with Infectious Diseases

    May 5, 2015

    Source: SHEA onlineLeading infectious diseases experts have released new guidance for healthcare facilities looking to establish precautions for visitors of patients with infectious diseases. The guidance looks to reduce the potential for healthcare visitors in spreading dangerous bacteria within the healthcare facility and community. The recommendations are published online in Infection Control & Hospital Epidemiology, […]



© 2004-2018 Global Life Technologies Corp. All rights reserved. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease.